Atlas Trials

Mismatch Repair Deficiency

19 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Mismatch Repair Deficiency

RecordFirmDate
Tislelizumab for the Treatment of Recurrent Mismatch Repair Deficient Endometrial Cancer (NCT04906382)Floor Backes, MD2021-07-01
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Advanced Solid Cancers (NCT03935893)Udai Kammula2019-12-03
Anti-PD-1 +/- RT for MSI-H Solid Tumors (NCT04001101)University of Colorado, Denver2019-10-10
The mCRC Patients With pMMR/MSS or dMMR/MSI-H Status Received Palliative Chemotherapy Efficacy and Survival (NCT04482608)Sun Yat-sen University2019-09-01
Frequency of Endometrial Cancer Precursors Associated with Lynch Syndrome (NCT05257057)WellSpan Health2019-05-08
QUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Immune Checkpoint Inhibitors (NCT03228667)ImmunityBio, Inc.2018-12-11
A Safety and Tolerability Study of INCAGN02390 in Select Advanced Malignancies (NCT03652077)Incyte Corporation2018-09-24
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry (NCT03452774)Massive Bio, Inc.2018-01-01
APL-501 Study for Select Advanced or Relapsed/Recurrent Solid Tumors (NCT03053466)Apollomics (Australia) Pty. Ltd.2017-03-27

Track Mismatch Repair Deficiency automatically

Every clearance here is in the API, with alerts when new ones post.